Importantly, knockdown of fbxo22 significantly reduced the responsiveness of lung cancer cells to deguelin, suggesting that the mechanism of deguelin action is dependent on the fbxo22/rad51 pathway. The gene discussed is FBXO22; the disease is lung carcinoma.